Parenteral manufacturing encompasses a variety of activities including compounding of sterile solutions, aseptic filling at ISO 5, terminal sterilisation, lyophilisation (freeze-drying), container closure integrity testing, visual inspection and final product release. The processes must be documented, validated equipment, trained personnel and strict environmental control each step of the way, and meet or exceed the requirements of regulatory authorities like the US FDA, EU GMP (Annex 1), WHO, PIC/S, MHRA, Health Canada and TGA Australia. The QA department has a dominant role – approving all the procedures, tracking environmental data, checking batch records and releasing only when all critical parameters are satisfied. In this section you will find the SOPs and the procedural documents for pharmaceutical injection manufacturing and the parenteral manufacturing which are in both PDF and Editable MS Word format. Every document is prepared to represent the present day GMP requirements in the world regulatory environment.
📋 List of Injection SOPs
- SOP for Disassembling, cleaning, and assembling Filter Housing
- SOP for Operation and cleaning of Tunnel sterilizer
- SOP for Cleaning and Storage of Filling accessories
- SOP for Operation and cleaning of lyophilizer
- SOP for Manual Visual inspection of filled vials
- SOP for Transfer of Semi packed material to warehouse
- SOP for Glass | Vial | Syringes Crushing Machine
- SOP on Operation and cleaning of the Bung Processor
- SOP Operating of Vials Labeling Machine
- Sop on Cleaning and Monitoring Aseptic area
- SOP for Dry Heat Sterilization in injection section
- SOP for Cleaning and Operation of vials washing machine
- SOP on Sterilized Powder filling machine
The following topics are covered in this section:
This section includes SOPs and reference documents for the entire range of parenteral and sterile injectable manufacturing. From production to packaging area, procedure templates and reference documents are available that meet the expectations of current GMP.
Frequently Asked Questions:
Ans: The parenterals manufacturing is subject to FDA 21CFR parts 210 and 211, EU GMP Annex 1 (Manufacture of Sterile Medicinal Products), WHO Technical Report Series, PIC/S PE 009, MHRA guidance and TGA requirements (Australia). In 2022, EU GMP Annex 1 was completely updated to become the global standard for contamination control strategy and the aseptic process requirements.
Ans: Terminal sterilisation involves sterilising the product in the final sealed container, by autoclave or dry heat processing, after filling. Aseptic processing involves the product, the container and the closure being individually sterilised and then being brought together in ISO 5 (Grade A) conditions.
Ans: The Core SOPs for a parenteral facility are: Aseptic Gowning and Qualification, Cleanroom Entry and Exit Procedures, Environmental Monitoring, Media Fill (Process Simulation), Equipment Sterilisation and Depyrogenation, WFI System Operation, Aseptic Fill Operations, Container Closure Integrity Testing, Visual Inspection, Batch Record Review, and OOS/Deviation Investigation. Each will need to be site specific, version controlled and approved by QA prior to implementation.
Ans: All these SOPs are drafted in accordance with the FDA and EU GMP requirements, which would comprise EU GMP Annex 1 (revision of 2022). They are reference templates and cannot be used as is. Each SOP should be customized to your specific equipment, validated parameters, site layout and internal document numbering for inspection readiness.
Ans: Yes. They not only cover theoretical knowledge, but demonstrate all the structure, content and language one would find in real pharmaceutical SOPs—ideal for placements, internships or early career positions in sterile production, QA or QC.